Microvascular Therapeutics is invited to pitch at the Canyon Angels event, October 4th! https://lnkd.in/gfAh4yV5
Microvascular Therapeutics’ Post
More Relevant Posts
-
A torn or jagged wound can be a real setback, but the far-infrared technology found in our devices could be your secret weapon for a quicker recovery. This innovative approach can speed up your healing process and get you back on track. Experience healing today with Gladiator Therapeutics! https://ow.ly/ub5450PUMJ0
To view or add a comment, sign in
-
The Future of Exosome Based Therapeutics: Key Clinical Updates ZEO ScientifiX™ invites you to a LIVE Webinar on The Future of Exosome Based Therapeutics with Dr. George Shapiro, MD https://lnkd.in/g5pnyr42
To view or add a comment, sign in
-
Head of Sustainability - EQT Private Capital (Europe & US); Voting partner of EQT Future Investment Committee; ex JLL
EQT Life Sciences EQT Group leads Series A financing in Cell Therapy company Shinobi Therapeutics. For the non life scientists, some insights from the press release..."Cell therapies have shown remarkable promise in treating blood cancers and other intractable diseases, but manufacturing costs render these therapies inaccessible to many patients around the world. Off-the-shelf cell therapies offer a more scalable manufacturing approach, but face the additional challenge of allo-rejection, as patients’ immune systems reject donor-derived and engineered cells as foreign invaders. To overcome this immune response, patients today receive immunosuppressive drugs before treatment, which can often result in unwanted side-effects and serious complications. Shinobi is taking a different approach by creating therapies that work with, not against, the patient’s immune system"
EQT Life Sciences Life Sciences Leads Oversubscribed $51M Series A in Cell-Therapy Company Shinobi Therapeutics. https://lnkd.in/egVXG5AZ
To view or add a comment, sign in
-
July Featured Article: Novel therapeutics for small abdominal aortic aneurysms: Recommendations for rodent model research @honglu227 @curciAAA @BloodVesselDoc1 https://lnkd.in/gKbpZ93r
To view or add a comment, sign in
-
Explore the Transformative Potential of OligoPhore™ / SemaPhore™ Technology: At Altamira Therapeutics, we're at the forefront of advancing #RNA therapeutics through pioneering science. Our technology has undergone rigorous testing in various standard murine models, utilizing both #siRNA and #mRNA payloads. Our relentless pursuit of innovation has yielded significant revelations in key features of the nanoparticles: - High stability - Extrahepatic delivery - Efficient endosomal escape - High selectivity - Safety Learn more about our #science: https://bit.ly/3ZH0E7G #RNATherapeutics
To view or add a comment, sign in
-
Halia Therapeutics, Inc.'s and Biolexis Therapeutics, Inc.'s partnership have identified a novel brain-penetrant small molecule candidate targeting NLRP3-driven neuroinflammation by leveraging Biolexis’ MolecuLern™ AI-enabled approach. This milestone represents a significant advancement in treatments for neuroinflammatory disorders, including Parkinson’s. #HaliaTherapeutics #BiolexisTherapeutics #BioUtah #UtahLifeSciences https://ow.ly/Jqow50SSyf2
To view or add a comment, sign in
-
Experienced turnaround CEO/ 2x Successful Exits / Biotech Angel - VC Investor / Executive Advisor / Veteran
Very interesting data and big potential to alter the landscape of oncology treatment..
Seneca Therapeutics Announces Publication of TEM8 Review Article “TEM8 in Oncogenesis” in Cells Journal https://buff.ly/3SKBfdo
To view or add a comment, sign in
-
In MA, Anthos Therapeutics is pioneering blood clot prevention with private equity support. Abelacimab, their anti blood clot treatment, achieved a 67% reduction in bleeding compared to existing treatments. Learn more: https://t.co/6Xt8x6t8VM #PrivateEquity #SmallBusiness
To view or add a comment, sign in
-
CRISPR-based therapeutics: cultivating a seamless transition from discovery to delivery with Synthego Corporation's John Walker! Register for this upcoming webinar and uncover methods for resolving impurities in clinical-grade sgRNAs >>> https://bit.ly/46BgVPn
To view or add a comment, sign in
342 followers